Dovato

(dolutegravir and lamivudine)

Dovato, a two-drug combination of dolutegravir (integrase strand transfer inhibitor [INSTI]) and lamivudine (nucleoside analogue reverse transcriptase inhibitor [NRTI]).

Prescribing Information, including boxed warning

Patient Information

Medical Information

Access Dovato medical content, including medical information letters and infographics.

Congress Data

Explore Dovato data presented at recent scientific congresses, including CROI, IDWeek, IAS, AIDS, EACS and HIV Glasgow.

Medical Videos

Watch Dovato medical videos, including on‑demand recordings from recent expert-led webinars.

Topical Video Shorts

View short, topic-focused Dovato medical videos with links to related medical information letters.

My MSL

Enter zip code to find your MSL contact.

Connect with ViiV Medical Experts

Call 1-888-226-8434
Weekdays from 8 AM to 6 PM ET
(5 AM – 3 PM PT)

Find my ViiV MSL

Request a scientific discussion

Report an Adverse Event

To report SUSPECTED ADVERSE REACTIONS, contact ViiV Healthcare at https://gsk.public.reportum.com or 1-877-844-8872, or FDA at 1-800-FDA-1088 or http://www.fda.gov/medwatch.

This site is intended for US Healthcare Professionals Only. It may include information about products or uses that have not been approved by the US Food and Drug Administration.

Trademarks are owned by or licensed to the ViiV Healthcare group of companies.